Antidiabetic vanadium (IV) and zinc (II) complexes
…, Y Kojima, Y Yoshikawa, K Kawabe, H Yasui - Coordination Chemistry …, 2002 - Elsevier
… (H 2 O) 2 ][Zn(ma) 2 (H 2 O)] · (H 2 O) 2 were revealed to be in a unit cell, where two maltols
and two H … conformation, and two maltols and an apical H 2 O molecule coordinate to a zinc(II…
and two H … conformation, and two maltols and an apical H 2 O molecule coordinate to a zinc(II…
Current state for the development of metallopharmaceutics and anti-diabetic metal complexes
H Sakurai, Y Yoshikawa, H Yasui - Chemical Society Reviews, 2008 - pubs.rsc.org
This tutorial review introduces the current state of metallopharmaceutics development by
focusing on the topics of anti-diabetic vanadium and zinc complexes. Over thousands of years, …
focusing on the topics of anti-diabetic vanadium and zinc complexes. Over thousands of years, …
Immunomodulatory function of lactic acid bacteria
H Yasui, K Shida, T Matsuzaki, T Yokokura - Antonie Van Leeuwenhoek, 1999 - Springer
Using mice, we found that oral administration of Bifidobacterium breve YIT4064 (B. breve)
activated the humoral immune system, augmented anti-rotavirus IgA production or anti-…
activated the humoral immune system, augmented anti-rotavirus IgA production or anti-…
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro …
…, JS Chen, LY Bai, SY Oh, Y Choda, H Yasui… - The Lancet …, 2022 - thelancet.com
Background The additive or synergistic sustained antitumour effect of immune checkpoint
inhibitors in combination with oxaliplatin-based chemotherapy has previously been reported. …
inhibitors in combination with oxaliplatin-based chemotherapy has previously been reported. …
Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo
…, Y Matsumoto, N Kajihara, M Eto, T Matsuda, H Yasui… - Circulation, 2004 - Am Heart Assoc
Background— Prognosis of ischemic cardiomyopathy still remains poor because of the lack
of effective treatments. To develop a noninvasive therapy for the disorder, we examined the …
of effective treatments. To develop a noninvasive therapy for the disorder, we examined the …
[HTML][HTML] A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib
Bortezomib therapy has proven successful for the treatment of relapsed and/or refractory
multiple myeloma (MM); however, prolonged treatment is associated with toxicity and …
multiple myeloma (MM); however, prolonged treatment is associated with toxicity and …
[HTML][HTML] Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer
…, A Tsuji, H Imamura, M Tsuda, H Yasui, H Fujii… - Annals of …, 2015 - Elsevier
Background We evaluated the efficacy and safety of S-1 plus oxaliplatin (SOX) as an alternative
to cisplatin plus S-1 (CS) in first-line chemotherapy for advanced gastric cancer (AGC). …
to cisplatin plus S-1 (CS) in first-line chemotherapy for advanced gastric cancer (AGC). …
Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis
…, H Yasui, L Jiang, H Ohara… - Proceedings of the …, 2011 - National Acad Sciences
… After a 24-h incubation, we used confocal microscopy to detect the fibers (23) and found
that HPMCs internalized Cro but not NT115, whereas macrophages phagocytosed both fibers (…
that HPMCs internalized Cro but not NT115, whereas macrophages phagocytosed both fibers (…
[PDF][PDF] Randomized, open-label, phase III study comparing irinotecan with paclitaxel in patients with advanced gastric cancer without severe peritoneal metastasis after …
S Hironaka, S Ueda, H Yasui, T Nishina, M Tsuda… - J clin …, 2013 - researchgate.net
… Boku N, Yamamoto S, Fukuda H, et al: Fluorouracil versus combination of irinotecan plus
cisplatin versus S-1 in metastatic gastric cancer: A randomised phase 3 study. Lancet Oncol …
cisplatin versus S-1 in metastatic gastric cancer: A randomised phase 3 study. Lancet Oncol …
Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
…, T Nakajima, N Nishida, K Yamaguchi, H Yasui… - Nature medicine, 2020 - nature.com
Comprehensive genomic profiling enables genomic biomarker detection in advanced solid
tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA) genotyping, we …
tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA) genotyping, we …